Zdrowie i gospodarka · 11.03.2011
Cancer Therapy Evaluation Program Intellectual Property Option to Collaborator
The National Cancer Institute, Division of Cancer Treatment and Diagnosis, is announcing the final revision of the NCI Cancer Therapy Evaluation Program's Intellectual Property Option to Collaborator.